S
CVS icon

SignatureFD’s CVS Health CVS Stock Holding History

SignatureFD’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Buy
19,914
+1,346
+7% +$104K 0.02% 313
2025
Q4 		$1.47M Buy
18,568
+4,217
+29% +$332K 0.02% 289
2025
Q3 		$1.08M Sell
14,351
-1,250
-8% -$85.7K 0.02% 367
2025
Q2 		$1.08M Sell
15,601
-4,322
-22% -$283K 0.02% 336
2025
Q1 		$1.35M Buy
19,923
+6,048
+44% +$362K 0.03% 263
2024
Q4 		$623K Sell
13,875
-3,511
-20% -$197K 0.01% 456
2024
Q3 		$1.09M Sell
17,386
-3,305
-16% -$193K 0.02% 308
2024
Q2 		$1.22M Sell
20,691
-7,520
-27% -$470K 0.02% 259
2024
Q1 		$2.25M Buy
28,211
+2,210
+8% +$169K 0.05% 142
2023
Q4 		$2.05M Sell
26,001
-321
-1% -$22.8K 0.05% 146
2023
Q3 		$1.84M Sell
26,322
-2,680
-9% -$190K 0.05% 144
2023
Q2 		$2M Buy
29,002
+2,470
+9% +$176K 0.05% 132
2023
Q1 		$1.97M Buy
26,532
+2,432
+10% +$204K 0.05% 124
2022
Q4 		$2.25M Sell
24,100
-579
-2% -$55.9K 0.07% 104
2022
Q3 		$2.35M Buy
24,679
+1,688
+7% +$167K 0.08% 77
2022
Q2 		$2.13M Sell
22,991
-23
-0.1% -$2.25K 0.07% 87
2022
Q1 		$2.33M Buy
23,014
+200
+0.9% +$21K 0.07% 97
2021
Q4 		$2.35M Buy
22,814
+1,269
+6% +$117K 0.07% 97
2021
Q3 		$1.83M Buy
21,545
+1,211
+6% +$101K 0.06% 109
2021
Q2 		$1.7M Buy
20,334
+1,741
+9% +$143K 0.07% 109
2021
Q1 		$1.4M Buy
18,593
+558
+3% +$40.6K 0.06% 120
2020
Q4 		$1.23M Buy
18,035
+1,281
+8% +$83.3K 0.06% 108
2020
Q3 		$978K Buy
16,754
+2,848
+20% +$177K 0.05% 135
2020
Q2 		$904K Sell
13,906
-1,088
-7% -$68.5K 0.05% 127
2020
Q1 		$890K Sell
14,994
-178
-1% -$11.9K 0.08% 105
2019
Q4 		$1.13M Buy
15,172
+4,929
+48% +$346K 0.08% 105
2019
Q3 		$646K Buy
10,243
+815
+9% +$48.3K 0.05% 158
2019
Q2 		$514K Buy
9,428
+4,524
+92% +$244K 0.04% 173
2019
Q1 		$264K Sell
4,904
-5,247
-52% -$324K 0.02% 304
2018
Q4 		$665K Sell
10,151
-1,727
-15% -$129K 0.06% 129
2018
Q3 		$935K Buy
11,878
+1,401
+13% +$100K 0.1% 106
2018
Q2 		$674K Buy
10,477
+49
+0.5% +$3.23K 0.08% 129
2018
Q1 		$649K Buy
10,428
+1,676
+19% +$120K 0.08% 102
2017
Q4 		$635K Sell
8,752
-416
-5% -$30.2K 0.08% 111
2017
Q3 		$746K Buy
9,168
+763
+9% +$60.4K 0.1% 82
2017
Q2 		$676K Buy
8,405
+472
+6% +$37.3K 0.1% 79
2017
Q1 		$623K Buy
7,933
+1,024
+15% +$81.8K 0.09% 90
2016
Q4 		$545K Sell
6,909
-254
-4% -$20.6K 0.09% 89
2016
Q3 		$637K Buy
7,163
+194
+3% +$18.3K 0.09% 78
2016
Q2 		$667K Sell
6,969
-419
-6% -$41.8K 0.1% 51
2016
Q1 		$766K Buy
7,388
+848
+13% +$82.5K 0.13% 43
2015
Q4 		$639K Sell
6,540
-2,621
-29% -$257K 0.12% 46
2015
Q3 		$884K Buy
9,161
+398
+5% +$41.8K 0.2% 29
2015
Q2 		$919K Buy
8,763
+504
+6% +$51.5K 0.2% 35
2015
Q1 		$852K Sell
8,259
-135
-2% -$13.7K 0.21% 37
2014
Q4 		$808K Buy
8,394
+2,747
+49% +$242K 0.2% 39
2014
Q3 		$449K Sell
5,647
-369
-6% -$29.1K 0.15% 56
2014
Q2 		$453K Buy
6,016
+69
+1% +$5.21K 0.16% 54
2014
Q1 		$445K Buy
5,947
+98
+2% +$6.92K 0.18% 43
2013
Q4 		$419K Buy
5,849
+215
+4% +$13.8K 0.15% 49
2013
Q3 		$320K Buy
5,634
+142
+3% +$8.46K 0.14% 56
2013
Q2 		$314K Buy
+5,492
New +$318K 0.16% 61

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SignatureFD's CVS Position: Q1 2026 in Review

SignatureFD increased its CVS Health (CVS) stake by 7.2% in Q1 2026, buying an estimated $104K and bringing the position to 19,914 shares worth $1.43M. The position accounts for 0.02% of the portfolio, ranked #313.

SignatureFD first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.35M in Q3 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • SignatureFD held 19,914 shares of CVS Health worth $1.43M as of Q1 2026.
  • SignatureFD bought 1,346 CVS Health shares in Q1 2026, an estimated $104K.
  • CVS Health made up 0.02% of SignatureFD's portfolio in Q1 2026, its #313 holding.
  • SignatureFD first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • SignatureFD's CVS Health position peaked at $2.35M in Q3 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.